AMARIN, the double challenge.
Amarin faces the double challenge of the complexities of the Pharmaceutical Industry, in addition to the unfavorable scenario in macroeconomic terms in Argentina. [...]
Blog
API characteristics for Transdermal Drug Delivery Systems
In order for an IFA to be administered through the skin, it must meet certain characteristics. [...]
Oral Thin Film(OTF)
An oral thin film (OTF) is a very thin film made up of a single or multilayer polymeric matrix applied in the mouth. [...]
Challenge of transdermal patches
The skin is an accessible and convenient way to administer medications But it has certain limitations. [...]
Introduction to Microneedles
In May 1971, Alza Corporation filed the first patent for a transdermal device that would be the forerunner of what we know today as microneedling. [...]
Dementia: current events and projections
We tell you what dementia is, and how it has become one of the main causes of disability and dependence among the elderly. We also review current pharmacological treatments. [...]
Anti-abuse formulations
There are formulations created to reduce the possibility of drug abuse and misuse, making it difficult to administer it in conditions other than those approved. [...]
Where Drugs substances finally goes?
Millions of people who take medication to cure or alleviate an illness never consider where the pharmacological substances contained in a drug ultimately end up. [...]
Myths and truths about transdermal patches
With the large amount of information found on the internet, it is often difficult for us to differentiate truth from myth or lie. That is why in this article we collect some claims of transdermal patches and if they are true or false. [...]
Dr. Roberto Gabach: “If it is difficult you plan, if it is impossible you try”
Dr. Gabach, our director & manager of New Projects, analyzes the present and gives us a preview of the future of Amarin and the transdermal market. [...]